SlideShare una empresa de Scribd logo
1 de 1
Descargar para leer sin conexión
The growth rate of compounds in
                                                                                                                                      development far exceeds population
                                                                                                                                      growth and the number of investigators
                                                                                                                                      remains mostly flat. Because of this, patient
                                                                                                                                      recruitment for clinical trials functions as a

                                                         in   Patient Recruitment                                                     bottleneck in the process. The industry has
                                                                                                                                      to increase its focus on Patient Recruitment.




    Priorities
Faster patient recruitment leads to fewer delays in clinical trials, which means getting drugs on the shelf quicker. So
why do only 2% of sponsors rank patient recruitment strategy as the most important when selecting a service provider?




                                                         What would 30% lower costs mean?

         47%                                             $1.5-$2M                          18-24 months                                          $1,111/day
                                                         Cost of an average                    Length of an average                      30% savings of an average Phase II Study.
                                                          Phase II Study.                         Phase II Study.

of clinical development
decision-makers would                                                                                                                                     vs.
  prefer a 30% lower
 clinical trial cost than
   10% faster patient
       recruitment                                 What would 10% faster patient                                                         $1,885,000/day
                                                   recruitment mean?                                                                     Revenue generated per day by The 100th
                                                                                                                                           best selling drug in 3Q2012 (Stelara)




    Viewpoints
Clinical trials involve five main groups, each with different views and motivations. Here’s what they’re saying
about clinical trials:




          69%                                       28%                                    76%                                70%                                233%

    said they have not                    said that inclusion/exclusion         said they are involved in             said the hardest part of                increase in patients
   participated in clinical                  criteria have the single           the right amount, or too               patient recruitment is              required per NDA from
    trials because they                    biggest impact on patient               many clinical trials.                     finding the                      1500 in the 1970s to
   were not made aware                        recruitment success.                                                      right investigators.               more than 5000 today.
        of any trials.


       Patients                           Site Coordinators                       Investigators                            Sponsors                                 FDA




    Implications


                                11%                                    37%                              39%                                    13%

                   of sites in a given trial fail              of sites in a given trial     of sites in a given trial meet           of sites in a given trial
                   to enroll a single patient                       under-enroll               their enrollment targets                exceed their targets




The patient recruitment methods with the highest value, tend to be the more traditional methods:



          Dr. Referral                                                                      Mail from Doctor                          Custom Website

                     Local Newspaper
                                                                   Radio
                                                                            Poster in Doctor’s Office
                                                                             Affinity Groups


  sources: clinicaltrials.gov, Tufts, ISR Reports Data                                                      Copyright 2013 Industry Standard Research | ISRreports.com | info@ISRreports.com

Más contenido relacionado

La actualidad más candente

Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...John Reites
 
Methods of patient recruitment
Methods of patient recruitmentMethods of patient recruitment
Methods of patient recruitmentswati2084
 
Predisposition to CAM-ICU Determinacy
Predisposition to CAM-ICU DeterminacyPredisposition to CAM-ICU Determinacy
Predisposition to CAM-ICU DeterminacyTroy Daniel
 
Pcori final writeup
Pcori final writeupPcori final writeup
Pcori final writeuphbocian14
 
Clinical trial recruitment overview
Clinical trial recruitment overviewClinical trial recruitment overview
Clinical trial recruitment overviewUsama Malik
 
Patients Recruitment Forecast in Clinical Trials
Patients Recruitment Forecast in Clinical TrialsPatients Recruitment Forecast in Clinical Trials
Patients Recruitment Forecast in Clinical TrialsCognizant
 
Best strategies for successful recruitment and retention
Best strategies for successful recruitment and retentionBest strategies for successful recruitment and retention
Best strategies for successful recruitment and retentionTrialJoin
 
Www.drugabuse.gov/sites/default/files/files/pami factsheet
Www.drugabuse.gov/sites/default/files/files/pami factsheetWww.drugabuse.gov/sites/default/files/files/pami factsheet
Www.drugabuse.gov/sites/default/files/files/pami factsheetMichael Melichar
 
Patient Recruitment Insights
Patient Recruitment InsightsPatient Recruitment Insights
Patient Recruitment InsightsDora Calderon
 
Local Treatment in Periodontal pocket Journal Presentation
Local Treatment in Periodontal pocket Journal PresentationLocal Treatment in Periodontal pocket Journal Presentation
Local Treatment in Periodontal pocket Journal PresentationDr. B.V.Parvathy
 
What Is Client Directed Outcome Informed
What Is Client Directed Outcome InformedWhat Is Client Directed Outcome Informed
What Is Client Directed Outcome InformedScott Miller
 
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2CDC NPIN
 
Patient recruitment into clinical trials presentation
Patient recruitment into clinical trials presentationPatient recruitment into clinical trials presentation
Patient recruitment into clinical trials presentationBeshr Nammouz
 
CROs Driving Changes in Patient Recruitment
CROs Driving Changes in Patient RecruitmentCROs Driving Changes in Patient Recruitment
CROs Driving Changes in Patient RecruitmentJohn Reites
 
5 myers hiv self-testing in new york city
5 myers hiv self-testing in new york city5 myers hiv self-testing in new york city
5 myers hiv self-testing in new york citySlidesShare_Foxtrot
 

La actualidad más candente (20)

Recruitment in cancer trials
Recruitment in cancer trials Recruitment in cancer trials
Recruitment in cancer trials
 
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
 
Methods of patient recruitment
Methods of patient recruitmentMethods of patient recruitment
Methods of patient recruitment
 
Clinical Trial Recruitment
Clinical Trial RecruitmentClinical Trial Recruitment
Clinical Trial Recruitment
 
Predisposition to CAM-ICU Determinacy
Predisposition to CAM-ICU DeterminacyPredisposition to CAM-ICU Determinacy
Predisposition to CAM-ICU Determinacy
 
Pcori final writeup
Pcori final writeupPcori final writeup
Pcori final writeup
 
Clinical trial recruitment overview
Clinical trial recruitment overviewClinical trial recruitment overview
Clinical trial recruitment overview
 
Patients Recruitment Forecast in Clinical Trials
Patients Recruitment Forecast in Clinical TrialsPatients Recruitment Forecast in Clinical Trials
Patients Recruitment Forecast in Clinical Trials
 
Lafposter2011 (2)
Lafposter2011 (2)Lafposter2011 (2)
Lafposter2011 (2)
 
Best strategies for successful recruitment and retention
Best strategies for successful recruitment and retentionBest strategies for successful recruitment and retention
Best strategies for successful recruitment and retention
 
Www.drugabuse.gov/sites/default/files/files/pami factsheet
Www.drugabuse.gov/sites/default/files/files/pami factsheetWww.drugabuse.gov/sites/default/files/files/pami factsheet
Www.drugabuse.gov/sites/default/files/files/pami factsheet
 
Patient Recruitment Insights
Patient Recruitment InsightsPatient Recruitment Insights
Patient Recruitment Insights
 
Local Treatment in Periodontal pocket Journal Presentation
Local Treatment in Periodontal pocket Journal PresentationLocal Treatment in Periodontal pocket Journal Presentation
Local Treatment in Periodontal pocket Journal Presentation
 
What Is Client Directed Outcome Informed
What Is Client Directed Outcome InformedWhat Is Client Directed Outcome Informed
What Is Client Directed Outcome Informed
 
handover publication Medical Care
handover publication Medical Carehandover publication Medical Care
handover publication Medical Care
 
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
 
Patient recruitment into clinical trials presentation
Patient recruitment into clinical trials presentationPatient recruitment into clinical trials presentation
Patient recruitment into clinical trials presentation
 
CROs Driving Changes in Patient Recruitment
CROs Driving Changes in Patient RecruitmentCROs Driving Changes in Patient Recruitment
CROs Driving Changes in Patient Recruitment
 
5 myers hiv self-testing in new york city
5 myers hiv self-testing in new york city5 myers hiv self-testing in new york city
5 myers hiv self-testing in new york city
 
E4P0815_PatientInterest_V6
E4P0815_PatientInterest_V6E4P0815_PatientInterest_V6
E4P0815_PatientInterest_V6
 

Similar a Infographic: The Bottleneck in Patient Recruitment

Transforming Drug Development at Lilly
Transforming Drug Development at LillyTransforming Drug Development at Lilly
Transforming Drug Development at LillyRahlyn Gossen
 
whitepaper - bytes not books uk.ashx
whitepaper - bytes not books uk.ashxwhitepaper - bytes not books uk.ashx
whitepaper - bytes not books uk.ashxLiz Pugh
 
Listening to the Patient - Leveraging Direct-to-Patient Data Collection to Sh...
Listening to the Patient - Leveraging Direct-to-Patient Data Collection to Sh...Listening to the Patient - Leveraging Direct-to-Patient Data Collection to Sh...
Listening to the Patient - Leveraging Direct-to-Patient Data Collection to Sh...John Reites
 
Solutions for Improving Patient Safety
Solutions for Improving Patient SafetySolutions for Improving Patient Safety
Solutions for Improving Patient SafetyISOB
 
Medication nonadherence cost and noncompliance in clinical trials
Medication nonadherence cost and noncompliance in clinical trialsMedication nonadherence cost and noncompliance in clinical trials
Medication nonadherence cost and noncompliance in clinical trialsSynegys
 
Therapeutic_Innovation_&_Regulatory_Science-2015-Tantsyura
Therapeutic_Innovation_&_Regulatory_Science-2015-TantsyuraTherapeutic_Innovation_&_Regulatory_Science-2015-Tantsyura
Therapeutic_Innovation_&_Regulatory_Science-2015-TantsyuraVadim Tantsyura
 
Testing times for clinical trials - Perscetives on personalised health care
Testing times for clinical trials - Perscetives on personalised health careTesting times for clinical trials - Perscetives on personalised health care
Testing times for clinical trials - Perscetives on personalised health careMats Sundgren
 
Top 5 tips for managing risks in your clinical studies - Pepgra
Top 5 tips for managing risks in your clinical studies - PepgraTop 5 tips for managing risks in your clinical studies - Pepgra
Top 5 tips for managing risks in your clinical studies - PepgraPEPGRA Healthcare
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialsUlrich Neumann, FRSA
 
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...Roberto Lara
 
Elsevier Interview - Dr Jorgensen - May 2015
Elsevier Interview - Dr Jorgensen - May 2015Elsevier Interview - Dr Jorgensen - May 2015
Elsevier Interview - Dr Jorgensen - May 2015jantrost
 
DN 703 Identifying a Target Population Research Paper.docx
DN 703 Identifying a Target Population Research Paper.docxDN 703 Identifying a Target Population Research Paper.docx
DN 703 Identifying a Target Population Research Paper.docxwrite5
 
Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Ajaz Hussain
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
 
Hospital Benefit Plans & Strategies Report
Hospital Benefit Plans & Strategies ReportHospital Benefit Plans & Strategies Report
Hospital Benefit Plans & Strategies Reportmatt_warner
 

Similar a Infographic: The Bottleneck in Patient Recruitment (20)

Transforming Drug Development at Lilly
Transforming Drug Development at LillyTransforming Drug Development at Lilly
Transforming Drug Development at Lilly
 
whitepaper - bytes not books uk.ashx
whitepaper - bytes not books uk.ashxwhitepaper - bytes not books uk.ashx
whitepaper - bytes not books uk.ashx
 
Re-visioning Radiology
Re-visioning RadiologyRe-visioning Radiology
Re-visioning Radiology
 
Listening to the Patient - Leveraging Direct-to-Patient Data Collection to Sh...
Listening to the Patient - Leveraging Direct-to-Patient Data Collection to Sh...Listening to the Patient - Leveraging Direct-to-Patient Data Collection to Sh...
Listening to the Patient - Leveraging Direct-to-Patient Data Collection to Sh...
 
Blatt e collaborative himss 2012 final
Blatt   e collaborative himss 2012 finalBlatt   e collaborative himss 2012 final
Blatt e collaborative himss 2012 final
 
Solutions for Improving Patient Safety
Solutions for Improving Patient SafetySolutions for Improving Patient Safety
Solutions for Improving Patient Safety
 
Medication nonadherence cost and noncompliance in clinical trials
Medication nonadherence cost and noncompliance in clinical trialsMedication nonadherence cost and noncompliance in clinical trials
Medication nonadherence cost and noncompliance in clinical trials
 
Therapeutic_Innovation_&_Regulatory_Science-2015-Tantsyura
Therapeutic_Innovation_&_Regulatory_Science-2015-TantsyuraTherapeutic_Innovation_&_Regulatory_Science-2015-Tantsyura
Therapeutic_Innovation_&_Regulatory_Science-2015-Tantsyura
 
Testing times for clinical trials - Perscetives on personalised health care
Testing times for clinical trials - Perscetives on personalised health careTesting times for clinical trials - Perscetives on personalised health care
Testing times for clinical trials - Perscetives on personalised health care
 
Top 5 tips for managing risks in your clinical studies - Pepgra
Top 5 tips for managing risks in your clinical studies - PepgraTop 5 tips for managing risks in your clinical studies - Pepgra
Top 5 tips for managing risks in your clinical studies - Pepgra
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trials
 
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
 
Elsevier Interview - Dr Jorgensen - May 2015
Elsevier Interview - Dr Jorgensen - May 2015Elsevier Interview - Dr Jorgensen - May 2015
Elsevier Interview - Dr Jorgensen - May 2015
 
DN 703 Identifying a Target Population Research Paper.docx
DN 703 Identifying a Target Population Research Paper.docxDN 703 Identifying a Target Population Research Paper.docx
DN 703 Identifying a Target Population Research Paper.docx
 
Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
Hospital Benefit Plans & Strategies Report
Hospital Benefit Plans & Strategies ReportHospital Benefit Plans & Strategies Report
Hospital Benefit Plans & Strategies Report
 
Future image
Future imageFuture image
Future image
 
Clorox Report
Clorox ReportClorox Report
Clorox Report
 
Data & Technology
Data & TechnologyData & Technology
Data & Technology
 

Más de Industry Standard Research

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Industry Standard Research
 
Electronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient RecruitmentElectronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient RecruitmentIndustry Standard Research
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensIndustry Standard Research
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresIndustry Standard Research
 
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)Industry Standard Research
 
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Industry Standard Research
 
Market Access: department models and structures
Market Access: department  models and structuresMarket Access: department  models and structures
Market Access: department models and structuresIndustry Standard Research
 
Infographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsInfographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsIndustry Standard Research
 
Infographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyInfographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyIndustry Standard Research
 
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)Industry Standard Research
 
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Infographic: Thyroid Cancer:  Disease and Pipeline AnalysisInfographic: Thyroid Cancer:  Disease and Pipeline Analysis
Infographic: Thyroid Cancer: Disease and Pipeline AnalysisIndustry Standard Research
 
Benchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsBenchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsIndustry Standard Research
 
Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Industry Standard Research
 
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentBrain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentIndustry Standard Research
 

Más de Industry Standard Research (20)

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
 
Electronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient RecruitmentElectronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient Recruitment
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment Regimens
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
 
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
 
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
 
Market Access: department models and structures
Market Access: department  models and structuresMarket Access: department  models and structures
Market Access: department models and structures
 
Infographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsInfographic: The World of Drug Development Trends
Infographic: The World of Drug Development Trends
 
Infographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyInfographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and Technology
 
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
 
Orphan Drug 101
Orphan Drug 101Orphan Drug 101
Orphan Drug 101
 
Infographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer ProfileInfographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer Profile
 
Infographic: CRO Capital Market
Infographic: CRO Capital MarketInfographic: CRO Capital Market
Infographic: CRO Capital Market
 
2014 Clinical Development Year in Review
2014 Clinical Development Year in Review2014 Clinical Development Year in Review
2014 Clinical Development Year in Review
 
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Infographic: Thyroid Cancer:  Disease and Pipeline AnalysisInfographic: Thyroid Cancer:  Disease and Pipeline Analysis
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
 
Benchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsBenchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs Functions
 
Bladder Cancer: profile and drug development
Bladder Cancer: profile and drug developmentBladder Cancer: profile and drug development
Bladder Cancer: profile and drug development
 
Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...
 
[Infographic] Lung Cancer
[Infographic] Lung Cancer[Infographic] Lung Cancer
[Infographic] Lung Cancer
 
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentBrain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
 

Último

Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 

Último (20)

Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 

Infographic: The Bottleneck in Patient Recruitment

  • 1. The growth rate of compounds in development far exceeds population growth and the number of investigators remains mostly flat. Because of this, patient recruitment for clinical trials functions as a in Patient Recruitment bottleneck in the process. The industry has to increase its focus on Patient Recruitment. Priorities Faster patient recruitment leads to fewer delays in clinical trials, which means getting drugs on the shelf quicker. So why do only 2% of sponsors rank patient recruitment strategy as the most important when selecting a service provider? What would 30% lower costs mean? 47% $1.5-$2M 18-24 months $1,111/day Cost of an average Length of an average 30% savings of an average Phase II Study. Phase II Study. Phase II Study. of clinical development decision-makers would vs. prefer a 30% lower clinical trial cost than 10% faster patient recruitment What would 10% faster patient $1,885,000/day recruitment mean? Revenue generated per day by The 100th best selling drug in 3Q2012 (Stelara) Viewpoints Clinical trials involve five main groups, each with different views and motivations. Here’s what they’re saying about clinical trials: 69% 28% 76% 70% 233% said they have not said that inclusion/exclusion said they are involved in said the hardest part of increase in patients participated in clinical criteria have the single the right amount, or too patient recruitment is required per NDA from trials because they biggest impact on patient many clinical trials. finding the 1500 in the 1970s to were not made aware recruitment success. right investigators. more than 5000 today. of any trials. Patients Site Coordinators Investigators Sponsors FDA Implications 11% 37% 39% 13% of sites in a given trial fail of sites in a given trial of sites in a given trial meet of sites in a given trial to enroll a single patient under-enroll their enrollment targets exceed their targets The patient recruitment methods with the highest value, tend to be the more traditional methods: Dr. Referral Mail from Doctor Custom Website Local Newspaper Radio Poster in Doctor’s Office Affinity Groups sources: clinicaltrials.gov, Tufts, ISR Reports Data Copyright 2013 Industry Standard Research | ISRreports.com | info@ISRreports.com